Atomic structures of Coxsackievirus A6 and its complex with a neutralizing antibody

Atomic structures of Coxsackievirus A6 and its complex with a neutralizing antibody

Coxsackievirus A6 (CVA6) causes hand, foot and mouth disease in children. Here the authors present the CVA6 procapsid and A-particle cryo-EM structures and identify an immune-dominant neutralizing epitope, which can be exploited for vaccine development.

Bibliographic Details
Main Authors:	Longfa Xu, Qingbing Zheng, Shaowei Li, Maozhou He, Yangtao Wu, Yongchao Li, Rui Zhu, Hai Yu, Qiyang Hong, Jie Jiang, Zizhen Li, Shuxuan Li, Huan Zhao, Lisheng Yang, Wangheng Hou, Wei Wang, Xiangzhong Ye, Jun Zhang, Timothy S. Baker, Tong Cheng, Z. Hong Zhou, Xiaodong Yan, Ningshao Xia
Format:	Article
Language:	English
Published:	Nature Portfolio 2017-09-01
Series:	Nature Communications
Online Access:	https://doi.org/10.1038/s41467-017-00477-9

Similar Items

Research progress and application prospects of animal models of group B Coxsackievirus infections
by: Shihan Weng, et al.
Published: (2025-12-01)

Crystal Structures of Two Immune Complexes Identify Determinants for Viral Infectivity and Type-Specific Neutralization of Human Papillomavirus
by: Zhihai Li, et al.
Published: (2017-11-01)

A potential therapeutic neutralization monoclonal antibody specifically against multi-coxsackievirus A16 strains challenge
by: Ruixiao Du, et al.
Published: (2019-10-01)

Molecular mechanism of antibody neutralization of coxsackievirus A16
by: Chao Zhang, et al.
Published: (2022-12-01)

Neutralization sites of human papillomavirus-6 relate to virus attachment and entry phase in viral infection
by: Xinlin Liu, et al.
Published: (2019-01-01)

T = 4 Icosahedral HIV-1 Capsid As an Immunogenic Vector for HIV-1 V3 Loop Epitope Display
by: Zhiqing Zhang, et al.
Published: (2018-11-01)

Evaluation of the cross-neutralization activities elicited by Coxsackievirus A10 vaccine strains
by: Yaqian Huo, et al.
Published: (2021-12-01)

A stepwise docking molecular dynamics approach for simulating antibody recognition with substantial conformational changes
by: Yang Huang, et al.
Published: (2022-01-01)

Comprehensive profiling of neutralizing polyclonal sera targeting coxsackievirus B3
by: Beatriz Álvarez-Rodríguez, et al.
Published: (2023-10-01)

A surrogate assay for measuring Coxsackievirus A6 neutralizing antibodies
by: Yao Su, et al.
Published: (2018-12-01)

A Bacterially Expressed SARS-CoV-2 Receptor Binding Domain Fused With Cross-Reacting Material 197 A-Domain Elicits High Level of Neutralizing Antibodies in Mice
by: Liqin Liu, et al.
Published: (2022-04-01)

Development of a pseudovirus-based assay for measuring neutralizing antibodies against Coxsackievirus A10
by: Kelei Li, et al.
Published: (2020-06-01)

In vivo time-related evaluation of a therapeutic neutralization monoclonal antibody against lethal enterovirus 71 infection in a mouse model.
by: Zhiqun Li, et al.
Published: (2014-01-01)

Comprehensive Overview of Broadly Neutralizing Antibodies against SARS-CoV-2 Variants
by: Lingyan Cui, et al.
Published: (2024-06-01)

Identification of a cross-neutralizing antibody that targets the receptor binding site of H1N1 and H5N1 influenza viruses
by: Tingting Li, et al.
Published: (2022-09-01)

Neutralization of interleukin-38 exacerbates coxsackievirus B3-induced acute myocarditis in mice
by: Yimin Xue, et al.
Published: (2021-11-01)

Etymologia: Coxsackievirus
Published: (2012-11-01)

A screening study on the detection strain of Coxsackievirus A6: the key to evaluating neutralizing antibodies in vaccines
by: Fan Gao, et al.
Published: (2024-12-01)

A single residue switch mediates the broad neutralization of Rotaviruses
by: Yang Huang, et al.
Published: (2025-01-01)

Single‐atom catalysis for carbon neutrality
by: Ligang Wang, et al.
Published: (2022-11-01)

Identification of a neutralizing linear epitope within the VP1 protein of coxsackievirus A10
by: Hanyu Zhu, et al.
Published: (2022-12-01)

Humoral and cellular immunogenicity and efficacy of a coxsackievirus A10 vaccine in mice
by: Huan-Huan An, et al.
Published: (2023-12-01)

Identification of Broad-Genotype HPV L2 Neutralization Site for Pan-HPV Vaccine Development by a Cross-Neutralizing Antibody.
by: Daning Wang, et al.
Published: (2015-01-01)

IL-9 inhibits viral replication in Coxsackievirus B3-induced myocarditis
by: Miao Yu, et al.
Published: (2016-10-01)

SARS-CoV-2 spike produced in insect cells elicits high neutralization titres in non-human primates
by: Tingting Li, et al.
Published: (2020-01-01)

Structural insight into broadening SARS-CoV-2 neutralization by an antibody cocktail harbouring both NTD and RBD potent antibodies
by: Wenling Jiang, et al.
Published: (2024-12-01)

Poorly neutralizing polyclonal antibody in vitro against coxsackievirus A16 circulating strains can prevent a lethal challenge in vivo
by: Xin Yao, et al.
Published: (2018-05-01)

Genotyping and phylogeographic dynamics of coxsackievirus A16
by: Xia-Nan Chu, et al.
Published: (2024-10-01)

Corrigendum: IL-9 inhibits viral replication in coxsackievirus B3-induced myocarditis
by: Miao Yu, et al.
Published: (2024-10-01)

Coxsackievirus A16 in Southern Vietnam
by: Nhu, LNT, et al.
Published: (2021)

Structure of a novel shoulder-to-shoulder p24 dimer in complex with the broad-spectrum antibody A10F9 and its implication in capsid assembly.
by: Ying Gu, et al.
Published: (2013-01-01)

N-terminal truncations on L1 proteins of human papillomaviruses promote their soluble expression in Escherichia coli and self-assembly in vitro
by: Minxi Wei, et al.
Published: (2018-09-01)

VP2 residue N142 of coxsackievirus A10 is critical for the interaction with KREMEN1 receptor and neutralizing antibodies and the pathogenicity in mice.
by: Xue Li, et al.
Published: (2023-10-01)

VP2 residue N142 of coxsackievirus A10 is critical for the interaction with KREMEN1 receptor and neutralizing antibodies and the pathogenicity in mice
by: Xue Li, et al.
Published: (2023-10-01)

Rational design of a triple-type human papillomavirus vaccine by compromising viral-type specificity
by: Zhihai Li, et al.
Published: (2018-12-01)

Epidemic and VP1 genetic characteristics of coxsackievirus A8 in Guangdong province, 2010 – 2020
by: Xiao-li CHEN, et al.
Published: (2023-02-01)

Towards single‐atom photocatalysts for future carbon‐neutral application
by: Dongpeng Zhang, et al.
Published: (2022-09-01)

Seroepidemiology of Coxsackievirus A6, Coxsackievirus A16, and Enterovirus 71 Infections among Children and Adolescents in Singapore, 2008-2010.
by: Li Wei Ang, et al.
Published: (2015-01-01)

Coxsackievirus A16 in Southern Vietnam
by: Le Nguyen Truc Nhu, et al.
Published: (2021-06-01)

Coxsackievirus Infection and Associated Diseases
by: Magloire Pandoua Nekoua, et al.
Published: (2022-08-01)